SKP2 regulates Bcr-Abl by inducing its K63-linked ubiquitination and subsequent activation, promoting the initiation and development of chronic myeloid leukemia (CML) [45]. Here, SKP2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.